CN102872376A - 护理或治疗糖尿病周围神经病变性疼痛的中药组合物 - Google Patents
护理或治疗糖尿病周围神经病变性疼痛的中药组合物 Download PDFInfo
- Publication number
- CN102872376A CN102872376A CN2012104166276A CN201210416627A CN102872376A CN 102872376 A CN102872376 A CN 102872376A CN 2012104166276 A CN2012104166276 A CN 2012104166276A CN 201210416627 A CN201210416627 A CN 201210416627A CN 102872376 A CN102872376 A CN 102872376A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- medicine composition
- diabetic peripheral
- neuropathic pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 116
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 208000032131 Diabetic Neuropathies Diseases 0.000 title claims abstract description 34
- 230000000474 nursing effect Effects 0.000 title claims abstract description 16
- 208000002193 Pain Diseases 0.000 title abstract description 33
- 230000036407 pain Effects 0.000 title abstract description 22
- 210000000582 semen Anatomy 0.000 claims abstract description 25
- 239000004863 Frankincense Substances 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 241001506304 Kadsura japonica Species 0.000 claims abstract 2
- 238000002360 preparation method Methods 0.000 claims description 25
- 241000756943 Codonopsis Species 0.000 claims description 24
- 239000009286 sanguis draxonis Substances 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000009636 Huang Qi Substances 0.000 claims description 20
- 239000002775 capsule Substances 0.000 claims description 20
- 239000004567 concrete Substances 0.000 claims description 20
- 241000717739 Boswellia sacra Species 0.000 claims description 19
- 241000628997 Flos Species 0.000 claims description 19
- 241001057584 Myrrha Species 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 230000001476 alcoholic effect Effects 0.000 claims description 14
- 229920001353 Dextrin Polymers 0.000 claims description 12
- 239000004375 Dextrin Substances 0.000 claims description 12
- 235000019425 dextrin Nutrition 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 238000004064 recycling Methods 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 10
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 8
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 7
- 239000008101 lactose Substances 0.000 claims description 7
- 241000545442 Radix Species 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 3
- 235000010234 sodium benzoate Nutrition 0.000 claims description 3
- 239000004299 sodium benzoate Substances 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 206010067482 No adverse event Diseases 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 235000002566 Capsicum Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 239000006002 Pepper Substances 0.000 abstract 1
- 235000016761 Piper aduncum Nutrition 0.000 abstract 1
- 235000017804 Piper guineense Nutrition 0.000 abstract 1
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 235000008184 Piper nigrum Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 244000186071 dragons blood palm Species 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000037040 pain threshold Effects 0.000 description 26
- 241000700159 Rattus Species 0.000 description 23
- 229940079593 drug Drugs 0.000 description 17
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 description 15
- 208000000114 Pain Threshold Diseases 0.000 description 15
- 230000000202 analgesic effect Effects 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 238000012360 testing method Methods 0.000 description 12
- 239000008280 blood Substances 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 11
- 238000003304 gavage Methods 0.000 description 11
- 208000004296 neuralgia Diseases 0.000 description 11
- 208000021722 neuropathic pain Diseases 0.000 description 11
- 230000001225 therapeutic effect Effects 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 10
- -1 reflux Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 238000011552 rat model Methods 0.000 description 8
- 239000012467 final product Substances 0.000 description 7
- 239000003390 Chinese drug Substances 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 238000011049 filling Methods 0.000 description 6
- 239000004570 mortar (masonry) Substances 0.000 description 6
- 229960002870 gabapentin Drugs 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241001506371 Kadsura Species 0.000 description 3
- 208000012902 Nervous system disease Diseases 0.000 description 3
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229960001052 streptozocin Drugs 0.000 description 3
- 206010018473 Glycosuria Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000001032 spinal nerve Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 208000003164 Diplopia Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000053227 Themus Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 206010029864 nystagmus Diseases 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 239000000014 opioid analgesic Substances 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003497 sciatic nerve Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 机械痛阈(g) | 热痛阈(s) |
正常组 | 14.10±2.25 | 10.52±0.16 |
模型组 | 4.32±0.44 | 2.24±0.18 |
加巴喷丁组 | 6.98±1.08# | 4.42±0.28# |
中药对照组 | 9.48±0.88##* | 6.56±0.36##* |
本发明中药组 | 11.38±0.78##*▲ | 8.9±0.56##*▲ |
组别 | 改善率(%) |
模型组 | 2.6±1.8 |
中药对照组 | 68.2±12.4## |
中药A组 | 98.2±18.6##* |
中药B组 | 100.4±22.4##* |
中药C组 | 111.8±16.6##*▲△ |
中药D组 | 112.4±20.2##*▲△ |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210416627.6A CN102872376B (zh) | 2012-10-28 | 2012-10-28 | 护理或治疗糖尿病周围神经病变性疼痛的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210416627.6A CN102872376B (zh) | 2012-10-28 | 2012-10-28 | 护理或治疗糖尿病周围神经病变性疼痛的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102872376A true CN102872376A (zh) | 2013-01-16 |
CN102872376B CN102872376B (zh) | 2014-06-04 |
Family
ID=47474046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210416627.6A Active CN102872376B (zh) | 2012-10-28 | 2012-10-28 | 护理或治疗糖尿病周围神经病变性疼痛的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102872376B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104225221A (zh) * | 2014-08-12 | 2014-12-24 | 刘倩 | 一种治疗糖尿病周围性神经病变的中药 |
CN106074660A (zh) * | 2016-08-11 | 2016-11-09 | 南京中医药大学 | 乳香和没药在制备防治神经病理性痛疾病药物中的应用 |
CN108159369A (zh) * | 2017-12-19 | 2018-06-15 | 银川市中医医院 | 治疗糖尿病周围神经病变的药物组合物 |
WO2018152614A1 (en) * | 2017-02-21 | 2018-08-30 | Fine Cotton Factory Inc. | Articles for treating concussion and other disorders |
CN114699452A (zh) * | 2022-03-18 | 2022-07-05 | 中国中医科学院西苑医院 | 一种治疗糖尿病周围神经病变的中药组合物、其制备方法和用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102151316A (zh) * | 2011-03-28 | 2011-08-17 | 曹广玲 | 一种治疗糖尿病周围神经病变性疼痛的中药组合物 |
CN102614464A (zh) * | 2012-03-31 | 2012-08-01 | 方召云 | 一种治疗糖尿病足的中药组合物 |
-
2012
- 2012-10-28 CN CN201210416627.6A patent/CN102872376B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102151316A (zh) * | 2011-03-28 | 2011-08-17 | 曹广玲 | 一种治疗糖尿病周围神经病变性疼痛的中药组合物 |
CN102614464A (zh) * | 2012-03-31 | 2012-08-01 | 方召云 | 一种治疗糖尿病足的中药组合物 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104225221A (zh) * | 2014-08-12 | 2014-12-24 | 刘倩 | 一种治疗糖尿病周围性神经病变的中药 |
CN104225221B (zh) * | 2014-08-12 | 2018-04-27 | 黑龙江中医药大学 | 一种治疗糖尿病周围性神经病变的中药 |
CN106074660A (zh) * | 2016-08-11 | 2016-11-09 | 南京中医药大学 | 乳香和没药在制备防治神经病理性痛疾病药物中的应用 |
WO2018152614A1 (en) * | 2017-02-21 | 2018-08-30 | Fine Cotton Factory Inc. | Articles for treating concussion and other disorders |
CN108159369A (zh) * | 2017-12-19 | 2018-06-15 | 银川市中医医院 | 治疗糖尿病周围神经病变的药物组合物 |
CN114699452A (zh) * | 2022-03-18 | 2022-07-05 | 中国中医科学院西苑医院 | 一种治疗糖尿病周围神经病变的中药组合物、其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN102872376B (zh) | 2014-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101444611B (zh) | 治疗腰腿痛、腰椎间盘突出症的中药组合物及其制备方法 | |
CN102872376B (zh) | 护理或治疗糖尿病周围神经病变性疼痛的中药组合物 | |
CN101711847B (zh) | 一种治疗抑郁症、焦虑症的口服中药制剂 | |
CN100382815C (zh) | 一种治疗风湿痹痛的药物组合物及其制剂 | |
CN102631579B (zh) | 一种治疗脑外伤后综合征的口服中药制剂 | |
CN102552454A (zh) | 治疗糖尿病足的中药 | |
CN104274789A (zh) | 一种治疗抑郁的中药组合物 | |
CN102631526B (zh) | 一种用于治疗糖尿病的中药组合物 | |
CN104606494A (zh) | 一种用于治疗肝癌的中药及其制备方法 | |
CN101607031B (zh) | 一种治疗和预防糖尿病的药酒及其制备方法和使用方法 | |
CN111437338A (zh) | 一种中药组合物在治疗皮肤病中的用途 | |
CN102552520B (zh) | 一种活血止痛胶囊及制备工艺和应用 | |
CN101249246B (zh) | 一种治疗脑梗死后抑郁的中成药制剂 | |
CN103520684B (zh) | 一种降血糖的中药复合物 | |
CN102151316A (zh) | 一种治疗糖尿病周围神经病变性疼痛的中药组合物 | |
CN102204956B (zh) | 一种用于中风恢复期的中药组合物及其制备方法 | |
CN106581299B (zh) | 一种改善中老年肾气虚证的中药组合物及其应用 | |
CN1931286A (zh) | 一种用于治疗肺癌等引起的轻、中度癌性疼痛属气滞血瘀证的中药组合物 | |
CN104436049A (zh) | 一种治疗心脏病的中药组合物 | |
CN102416147B (zh) | 一种治疗戒毒人员的躁狂症的药物组合物 | |
CN1943661A (zh) | 一种中药组合物及其制备方法 | |
CN108635457A (zh) | 一种治疗便秘的中药组合物及其制备方法与应用 | |
CN114306497B (zh) | 一种治疗肾虚血瘀型骨质疏松症的中药组合物、制剂与应用 | |
CN1306830A (zh) | 一种治疗ⅱ型糖尿病的药物 | |
CN100534482C (zh) | 治疗血管性头痛的软胶囊 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: YANG XIANHUA Free format text: FORMER OWNER: CHEN XINGWANG Effective date: 20140506 |
|
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Xing Yehong Inventor after: Yin Jizhen Inventor before: Wang Hongmei |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG HONGMEI TO: XING YEHONG YIN JIZHEN |
|
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140506 Address after: 276017, Shandong Linyi hi tech Zone Innovation Building, Room 201, Di Di science and Technology Information Service Center Applicant after: Yang Xianhua Address before: Three village Chu Dun Zhen 276017 Shandong province Linyi city Luozhuang District No. 89 group Applicant before: Chen Xingwang |
|
ASS | Succession or assignment of patent right |
Owner name: NANTONG HAOYOUXIAN AQUATIC FOOD CO., LTD. Free format text: FORMER OWNER: YANG XIANHUA Effective date: 20140801 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 276017 LINYI, SHANDONG PROVINCE TO: 226200 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140801 Address after: 226200 Qidong City, Jiangsu Province, Lu Lu, the Marine Economic Development Zone, four Patentee after: Nantong good and fresh aquatic food Co., Ltd. Address before: 276017, Shandong Linyi hi tech Zone Innovation Building, Room 201, Di Di science and Technology Information Service Center Patentee before: Yang Xianhua |